Study to Verify the Feasibility of Collecting a Broad Variety of Individual Health Data
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03135678|
Recruitment Status : Completed
First Posted : May 1, 2017
Last Update Posted : May 31, 2017
The purpose of the OBSERVE PILOT is to verify the feasibility of collecting individual health data which is obtained through blood samples, continuous monitoring devices, medical imaging, a questionnaire, and a blood pressure monitor.
Feasibility of collecting individual health data within the OBSERVE PILOT is described as the ease of gathering a broad variety of data by assessing: (1) the willingness of the subjects to participate in the study, (2) the logistics corresponding with the variety, and (3) the regulatory aspects of gathering a broad variety of data.
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||12 participants|
|Target Follow-Up Duration:||1 Week|
|Official Title:||Observe Pilot, a Prospective Study to Verify the Feasibility of Collecting a Broad Variety of Individual Health Data|
|Actual Study Start Date :||May 12, 2017|
|Actual Primary Completion Date :||May 23, 2017|
|Actual Study Completion Date :||May 23, 2017|
- The number of subjects willing to join the study [ Time Frame: Through study completion, an average of 6 months ]The number of subjects invited compared to the number of patients willing to join
- The number of health data types that were measured [ Time Frame: Through study completion, an average of 6 months ]The number of health data types that were measured compared to the number of health data types anticipated
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03135678
|Antwerp, Belgium, 2018|
|Principal Investigator:||Stefan Verheye, MD, PhD||Director at Hilbert Paradox|